Friday, 23 Mar 2018


Datesort ascending Type Title Save
03 Nov 2017 Social Study of 432 rural women shows Knee OA increases w/ age (OR 2.4-4.4), manual work,+FHx, but is 50% less in smokers
01 Nov 2017 Social Aussie Rheum DONT DOs 1) Arthrosopic lavage OA knee; 2) ANA w/o SLE sx; 3) reflex imaging of LBP; 4) dsDNA in ANA-
09 Oct 2017 News Zilretta - a New Drug FDA Approved for Osteoarthritis of the Knee
27 Sep 2017 Social In Australia 2015 to 2030, OA numbers are expected to incr 41%; RA by 37%, with cost of care rising by 37% for both.
27 Sep 2017 News UAB Researchers Shed Light on Age-Related Osteoporosis
21 Sep 2017 News Osteoporotic Fractures as Back Pain in Older Men
19 Sep 2017 News Romosuzumab Followed by Alendronate is Best in Fracture Prevention
18 Sep 2017 Social 50 pt trial of steroid injx vs wrist splinting for carpal tunnel syndr shows injx w/ better dexterity, satisfaction
14 Sep 2017 Social After 3-5yrs bisphosphonates in postmenopausal OP women, BP Drug holiday assoc w/ 40% higher risk of new fractures
05 Sep 2017 Social RT @ProfDavidHunter: Suggestions that the knee injection technique (approach) can influence treatment efficacy http…
04 Sep 2017 Social RT @philipcrobinson: Really interesting article on observation that beta blockers reduce joint pain and opioid use in osteoarthritis #OA ht…
04 Sep 2017 Social RT @jesdaile: The best long-term solution for arthritis is research on prevention and control
21 Aug 2017 Social In UK, RA + OA Arthritis will cause 25.9 million lost working days costing £3.43 billion by 2030
17 Aug 2017 News Bad Knees Through the Ages
17 Aug 2017 News Osteoporosis Care for RA Patients Found Suboptimal, Declining
13 Aug 2017 Social Hip & Knee pain is linked to Increasing Temperature (betw -5 & 30C), Not Rainfall
11 Aug 2017 News Kids with Crohn's have Profound MSK Deficits - but No Increase in Fractures
10 Aug 2017 News Joint Pain Linked to Increasing Temperature, Not Rainfall
02 Aug 2017 News Romosuzumab Outperforms Teriparatide in Post-Bisphosphonate Osteoporosis
02 Aug 2017 Social Amgen submitted its Biologic Licence application to the FDA for Denosumab in Rx of Glucorticoid induced Osteoporosis